Sfoglia per Titolo
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
2017-03-17 Franzese, O; Torino, F; Fuggetta, M; Aquino, A; Roselli, M; Bonmassar, E; Giuliani, A; D'Atri, S
Tumor in 3d: in vitro complex cellular models to improve nano-drugs cancer therapy
2020-05-31 Fernandes, S; Cassani, M; Pagliari, S; Filipensky, P; Cavalieri, F; Forte, G
Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin
1987-01-01 Macchia, V; Mariano, A; Cavalcanti, M; Coppa, A; Cecere, C; Fraioli, G; Elia, S; Ferrante, G
Tumor markers as targets for selective diagnostic and therapeutic procedures
1996-01-01 Roselli, M; Guadagni, F; Buonomo, O; Belardi, A; Ferroni, P; Diodati, A; Anselmi, D; Cipriani, C; Casciani, Cu; Greiner, J; Schlom, J
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion
2023-01-01 Lucarini, V; Nardozi, D; Angiolini, V; Benvenuto, M; Focaccetti, C; Carrano, R; Besharat, Z; Bei, R; Masuelli, L
Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth Differ. 2002 Jan;13(1):13-8.
2002-01-01 Miscia, S; Marchisio, M; Grilli, A; Di Valerio, V; Centurione, L; Sabatino, G; Garaci, F; Zauli, G; Bonvini, E; Di Baldassarre, A
Tumor necrosis factor alters synaptic transmission in rat hippocampal slices
1992-11-09 Tancredi, V; D'Arcangelo, G; Grassi, F; Tarroni, P; Palmieri, G; Santoni, A; Eusebi, F
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
2018-05-14 Rizzo, Fr; Musella, A; De Vito, F; Fresegna, D; Bullitta, S; Vanni, V; Guadalupi, L; Stampanoni Bassi, M; Buttari, F; Mandolesi, G; Centonze, D; Gentile, A
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration
2013-07-25 Rossi, S; Motta, C; Studer, V; Barbieri, F; Buttari, F; Bergami, A; Sancesario, G; Bernardini, S; De Angelis, G; Martino, G; Furlan, R; Centonze, D
Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus.
2011-01-01 Giardina, E; Hüffmeier, U; Ravindran, J; Behrens, F; Lepre, T; Mchugh, N; Korendowych, E; Burkhardt, H; Novelli, G; Reis, A
Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy
2020-01-01 Passarelli, C; Selvatici, R; Carrieri, A; Di Raimo, Fr; Falzarano, Ms; Fortunato, F; Rossi, R; Straub, V; Bushby, K; Reza, M; Zharaieva, I; D'Amico, A; Bertini, E; Merlini, L; Sabatelli, P; Borgiani, P; Novelli, G; Messina, S; Pane, M; Mercuri, E; Claustres, M; Tuffery-Giraud, S; Aartsma-Rus, A; Spitali, P; T'Hoen, Pac; Lochmüller, H; Strandberg, K; Al-Khalili, C; Kotelnikova, E; Lebowitz, M; Schwartz, E; Muntoni, F; Scapoli, C; Ferlini, A
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease
2008-01-01 Schinzari, F; Armuzzi, A; De Pascalis, B; Mores, N; Tesauro, M; Melina, D; Cardillo, C
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
2008-01-01 Schinzari, F; Armuzzi, A; De Pascalis, B; Mores, N; Tesauro, M; Melina, D; Cardillo, C
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome
2008-07-01 Tesauro, M; Schinzari, F; Rovella, V; Melina, D; Mores, N; Barini, A; Mettimano, M; Lauro, D; Iantorno, M; Quon, M; Cardillo, C
Tumor necrosis factor-α, interleukin-10, and α-defensins in plasma and breast milk of HIV-infected highly active antiretroviral therapy-treated and untreated pregnant women in Mozambique
2008-04-01 Baroncelli, S; Andreotti, M; Guidotti, G; Pirillo, M; Ceffa, S; Mancini, M; Germano, P; Marazzi, M; Vella, S; Palombi, L; Giuliano, M
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie's disease. A biomolecular study of apoptosis activation
2011-01-01 Loreto, C; Barbagli, G; Djinovic, R; Vespasiani, G; Carnazza, M; Miano, R; Musumeci, G; Sansalone, S
Tumor necrosis factor-α antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome
2008-01-01 Tesauro, M; Schinzari, F; Rovella, V; Melina, D; Mores, N; Barini, A; Mettimano, M; Lauro, D; Iantorno, M; Quon, M; Cardillo, C
Tumor seeding in urological laparoscopy: an international survey
2004-06-01 Micali, S; Celia, A; Bove, P; De Stefani, S; Sighinolfi, M; Kavoussi, L; Bianchi, G
Tumor suppressive Ca2+ signaling is driven by IP3 receptor fitness
2017-11-01 Bultynck, G; Campanella, M
Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases
2009-08-14 Sacco, F; Tinti, M; Palma, A; Ferrari, E; Nardozza, A; Hooft van Huijsduijnen, R; Takahashi, T; Castagnoli, L; Cesareni, G
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
17-mar-2017 | Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors | Franzese, O; Torino, F; Fuggetta, M; Aquino, A; Roselli, M; Bonmassar, E; Giuliani, A; D'Atri, S | Articolo su rivista | |
31-mag-2020 | Tumor in 3d: in vitro complex cellular models to improve nano-drugs cancer therapy | Fernandes, S; Cassani, M; Pagliari, S; Filipensky, P; Cavalieri, F; Forte, G | Articolo su rivista | |
1-gen-1987 | Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin | Macchia, V; Mariano, A; Cavalcanti, M; Coppa, A; Cecere, C; Fraioli, G; Elia, S; Ferrante, G | Articolo su rivista | |
1-gen-1996 | Tumor markers as targets for selective diagnostic and therapeutic procedures | Roselli, M; Guadagni, F; Buonomo, O; Belardi, A; Ferroni, P; Diodati, A; Anselmi, D; Cipriani, C; Casciani, Cu; Greiner, J; Schlom, J | Articolo su rivista | |
1-gen-2023 | Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion | Lucarini, V; Nardozi, D; Angiolini, V; Benvenuto, M; Focaccetti, C; Carrano, R; Besharat, Z; Bei, R; Masuelli, L | Articolo su rivista | |
1-gen-2002 | Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth Differ. 2002 Jan;13(1):13-8. | Miscia, S; Marchisio, M; Grilli, A; Di Valerio, V; Centurione, L; Sabatino, G; Garaci, F; Zauli, G; Bonvini, E; Di Baldassarre, A | Articolo su rivista | |
9-nov-1992 | Tumor necrosis factor alters synaptic transmission in rat hippocampal slices | Tancredi, V; D'Arcangelo, G; Grassi, F; Tarroni, P; Palmieri, G; Santoni, A; Eusebi, F | Articolo su rivista | |
14-mag-2018 | Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation | Rizzo, Fr; Musella, A; De Vito, F; Fresegna, D; Bullitta, S; Vanni, V; Guadalupi, L; Stampanoni Bassi, M; Buttari, F; Mandolesi, G; Centonze, D; Gentile, A | Articolo su rivista | |
25-lug-2013 | Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration | Rossi, S; Motta, C; Studer, V; Barbieri, F; Buttari, F; Bergami, A; Sancesario, G; Bernardini, S; De Angelis, G; Martino, G; Furlan, R; Centonze, D | Articolo su rivista | |
1-gen-2011 | Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus. | Giardina, E; Hüffmeier, U; Ravindran, J; Behrens, F; Lepre, T; Mchugh, N; Korendowych, E; Burkhardt, H; Novelli, G; Reis, A | Articolo su rivista | |
1-gen-2020 | Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy | Passarelli, C; Selvatici, R; Carrieri, A; Di Raimo, Fr; Falzarano, Ms; Fortunato, F; Rossi, R; Straub, V; Bushby, K; Reza, M; Zharaieva, I; D'Amico, A; Bertini, E; Merlini, L; Sabatelli, P; Borgiani, P; Novelli, G; Messina, S; Pane, M; Mercuri, E; Claustres, M; Tuffery-Giraud, S; Aartsma-Rus, A; Spitali, P; T'Hoen, Pac; Lochmüller, H; Strandberg, K; Al-Khalili, C; Kotelnikova, E; Lebowitz, M; Schwartz, E; Muntoni, F; Scapoli, C; Ferlini, A | Articolo su rivista | |
1-gen-2008 | Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease | Schinzari, F; Armuzzi, A; De Pascalis, B; Mores, N; Tesauro, M; Melina, D; Cardillo, C | Articolo su rivista | |
1-gen-2008 | Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. | Schinzari, F; Armuzzi, A; De Pascalis, B; Mores, N; Tesauro, M; Melina, D; Cardillo, C | Articolo su rivista | |
1-lug-2008 | Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome | Tesauro, M; Schinzari, F; Rovella, V; Melina, D; Mores, N; Barini, A; Mettimano, M; Lauro, D; Iantorno, M; Quon, M; Cardillo, C | Articolo su rivista | |
1-apr-2008 | Tumor necrosis factor-α, interleukin-10, and α-defensins in plasma and breast milk of HIV-infected highly active antiretroviral therapy-treated and untreated pregnant women in Mozambique | Baroncelli, S; Andreotti, M; Guidotti, G; Pirillo, M; Ceffa, S; Mancini, M; Germano, P; Marazzi, M; Vella, S; Palombi, L; Giuliano, M | Articolo su rivista | |
1-gen-2011 | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie's disease. A biomolecular study of apoptosis activation | Loreto, C; Barbagli, G; Djinovic, R; Vespasiani, G; Carnazza, M; Miano, R; Musumeci, G; Sansalone, S | Articolo su rivista | |
1-gen-2008 | Tumor necrosis factor-α antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome | Tesauro, M; Schinzari, F; Rovella, V; Melina, D; Mores, N; Barini, A; Mettimano, M; Lauro, D; Iantorno, M; Quon, M; Cardillo, C | Articolo su rivista | |
1-giu-2004 | Tumor seeding in urological laparoscopy: an international survey | Micali, S; Celia, A; Bove, P; De Stefani, S; Sighinolfi, M; Kavoussi, L; Bianchi, G | Articolo su rivista | |
1-nov-2017 | Tumor suppressive Ca2+ signaling is driven by IP3 receptor fitness | Bultynck, G; Campanella, M | Articolo su rivista | |
14-ago-2009 | Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases | Sacco, F; Tinti, M; Palma, A; Ferrari, E; Nardozza, A; Hooft van Huijsduijnen, R; Takahashi, T; Castagnoli, L; Cesareni, G | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile